PT - JOURNAL ARTICLE AU - Shokoofeh Nourbakhsh AU - Aamir Fazil AU - Michael Li AU - Chand S. Mangat AU - Shelley W. Peterson AU - Jade Daigle AU - Stacie Langner AU - Jayson Shurgold AU - Patrick D’Aoust AU - Robert Delatolla AU - Elizabeth Mercier AU - Xiaoli Pang AU - Bonita E. Lee AU - Rebecca Stuart AU - Shinthuja Wijayasri AU - David Champredon TI - A Wastewater-Based Epidemic Model for SARS-CoV-2 with Application to Three Canadian Cities AID - 10.1101/2021.07.19.21260773 DP - 2021 Jan 01 TA - medRxiv PG - 2021.07.19.21260773 4099 - http://medrxiv.org/content/early/2021/07/25/2021.07.19.21260773.short 4100 - http://medrxiv.org/content/early/2021/07/25/2021.07.19.21260773.full AB - The COVID-19 pandemic has stimulated wastewater-based surveillance, allowing public health to track the epidemic by monitoring the concentration of the genetic fingerprints of SARS-CoV-2 shed in wastewater by infected individuals. Wastewater-based surveillance for COVID-19 is still in its infancy. In particular, the quantitative link between clinical cases observed through traditional surveillance and the signals from viral concentrations in wastewater is still developing and hampers interpretation of the data and actionable public-health decisions.We present a modelling framework that includes both SARS-CoV-2 transmission at the population level and the fate of SARS-CoV-2 RNA particles in the sewage system after faecal shedding by infected persons in the population.Using our mechanistic representation of the combined clinical/wastewater system, we perform exploratory simulations to quantify the effect of surveillance effectiveness, public-health interventions and vaccination on the discordance between clinical and wastewater signals. We also apply our model to surveillance data from three Canadian cities to provide wastewater-informed estimates for the actual prevalence, the effective reproduction number and incidence forecasts. We find that wastewater-based surveillance, paired with this model, can complement clinical surveillance by supporting the estimation of key epidemiological metrics and hence better triangulate the state of an epidemic using this alternative data source.Competing Interest StatementThe authors have declared no competing interest.Funding StatementRD: Funding by Ontario Ministry of Environment Conservation and Parks Wastewater Surveillance Initiative Transfer Payment Agreement 2020-11-1-1463261970. All other authors do not report specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:data is anonymized, no IRB or ethics committee approval was needed.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data to reproduce this work will be available as a supplementary file upon publication.